Mass spectrometry-based assay detects viral antigens directly from clinical specimens - Insights
In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity...
A Test in Focus Archives - Page 10 of 10 - Insights
Skip to Content MayoACCESS MayoLINK...
Learn more about our pediatric oncology testing, which was carefully developed by a team of experts to provide efficient, actionable answers.
Learn more about our comprehensive menu of COVID-19 molecular, serology, and related testing.
Subspecialty testing - Insights
Check out Mayo Clinic Laboratories’ comprehensive selection of pathology testing, which can guide diagnosis of malignancies and other diseases.
Malabsorption - Mayo Clinic Laboratories
Stool testing is a critical component of diagnosing EPI and Mayo Clinic Laboratories offers multiple tests to help clinicians in their work-up of these patients.
Learn about our full suite of leukemia testing protocols, including includes flow cytometry, chromosome, FISH, and molecular testing.
Benign Hematology Testing - Mayo Clinic Laboratories
Our metabolic hematology laboratory is dedicated to providing accurate diagnoses and interpretations with an emphasis on clinical significance for your patients.
Diagnosis and inflammation monitoring - Insights
Patients with symptoms that arouse clinical suspicion of either inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) are both common and tough to differentiate.
Exploratory testing - Insights
Mayo Clinic Laboratories’ whole exome and whole genome sequencing assays provide in-depth interrogation of all the genes in the human genome, offering individualized insights for optimal outcomes.